HTTP/1.0 200 OK Cache-Control: private, must-revalidate Content-Type: text/html; charset=UTF-8 Date: Thu, 26 Nov 2020 20:50:54 GMT Expires: -1 Pragma: no-cache 名爵iOS系统 北京楼市升温新盘供不应求 房价或进入上升通道
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May 15;10.1111/head.13841.
doi: 10.1111/head.13841. Online ahead of print.

Headaches During COVID-19: My Clinical Case and Review of the Literature

Affiliations
Free PMC article

Headaches During COVID-19: My Clinical Case and Review of the Literature

Robert Belvis. Headache. .
Free PMC article

Abstract

Objective: To analyze headaches related to COVID-19 based on personal case experience.

Background: COVID-19 is an infection caused by the new coronavirus SARS-CoV-2. The first reported case happened in Wuhan on December 1, 2019. At present, at least 1.8 million people are infected around the world and almost 110,000 people have died. Many studies have analyzed the clinical picture of COVID-19, but they are focused on respiratory symptoms and headache is generically treated.

Methods: I describe and discuss my headaches during my COVID-19 and I review the MEDLINE literature about headaches and COVID-19.

Results: More than 41,000 COVID-19 patients have been included in clinical studies and headache was present in 8%-12% of them. However, no headache characterization was made in these studies. As a headache expert and based on my own personal clinical case, headaches related to COVID-19 can be classified in the 2 phases of the disease. Acute headache attributed to systemic viral infection, primary cough headache, tension-type headache and headache attributed to heterophoria can appear in the first phase (the influenza-like phase); and headache attributed to hypoxia and a new headache, difficult to fit into the ICHD3, can appear if the second phase (the cytokine storm phase) occurs.

Conclusions: Several headaches can appear during COVID-19 infection. All of them are headaches specified in the ICHD3, except 1 that occurs from the 7th day after the clinical onset. This headache is probably related to the cytokine storm that some patients suffer and it could be framed under the ICHD3 headache of Headache attributed to other non-infectious inflammatory intracranial disease. Although the reported prevalence of headaches as a symptom of COVID-19 infection is low, this experience shows that, very probably, it is underestimated.

Keywords: COVID-19; SARS-CoV-12; coronavirus; cytokine storm; headache.

Figures

Fig. 1
Fig. 1
Chest radiography showing bilateral infiltrations in the lung parenchyma suggestive of COVID‐19 pneumonia.

Similar articles

Cited by 12 articles

References

    1. Zhou M, Zhang X, Qu J. Coronavirus disease 2019 (COVID‐19): A clinical update. Front Med. 2020;10. doi:10.1007/s11684-020-0767-8. - 搭建平台租售并举 佛山今年已有探索 - 北京东部改善型稀少 东坝集中开发“解渴” - 雄安新区从准备阶段向规划实施阶段做准备
    1. Adhikari SP, Meng S, Wu YJ, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID‐19) during the early outbreak period: A scoping review. Infect Dis Poverty. 2020;9:29. - 2016年家博会即将开幕 物联网智能家居将成亮点 - 2017年门窗幕墙将华丽转身 创新求发展
    1. Hui DS, Wong PC, Wang C. SARS: Clinical features and diagnosis. Respirology. 2003;8:S20‐S24. - 雷士照明吴长江涉嫌挪用资金被立案侦查 - 创意家居抢占市场 市场看重实用性
    1. Shehata MM, Gomaa MR, Ali MA, Kayali G. Middle East respiratory syndrome coronavirus: A comprehensive review. Front Med. 2016;10:120‐136. - 建材领域首部节能减排评价体系将出台 - 租赁试点方案相继出台 轻租重售在改变
    1. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 2020;395:507‐513. - 北京88个京津冀协同发展项目完成建安投资418亿元 - 河北去年压减水泥产能1716万吨化解产能过剩

LinkOut - more resources

  • Full Text Sources

  • Miscellaneous

Feedback